By Sukriti Gupta (Reuters) -European shares were little changed on Monday, as investors awaited details on the U.S.-China ...

The US FDA has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg oral formulation of Wegovy ...

Plainsboro, New Jersey Monday, May 5, 2025, 14:00 Hrs [IST] ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

These three stocks could potentially help investors create a stable – and growing – stream of passive income in the years ...

We recently compiled a list of the 12 Best Stocks to Buy and Hold For 10 Years. In this article, we are going to take a look ...

This report covers recent developments in the health sector, including proposed US federal budget cuts affecting scientific ...

The Trump administration proposes significant budget cuts affecting health and research sectors. Texas reports 683 measles cases amid nationwide outbreaks. Medical device demand boosts Stryker's ...

When the stock market experiences a sharp decline, as it did after the Trump administration announced tariffs on its trade ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

PRESS RELEASE FROM THE MINISTRY OF HEALTH AND HUMAN SERVICES Cockburn Town, Turks and Caicos Islands, 2nd May 2025: In ...

Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on the ...